A detailed history of Susquehanna International Group, LLP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 715,157 shares of BBIO stock, worth $17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
715,157
Previous 676,649 5.69%
Holding current value
$17 Million
Previous $17.1 Million 6.23%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.91 - $31.3 $920,726 - $1.21 Million
38,508 Added 5.69%
715,157 $18.2 Million
Q2 2024

Aug 15, 2024

BUY
$23.0 - $31.04 $14.2 Million - $19.2 Million
618,296 Added 1059.58%
676,649 $17.1 Million
Q1 2024

May 07, 2024

SELL
$27.35 - $40.45 $1.2 Million - $1.78 Million
-43,962 Reduced 42.97%
58,353 $1.8 Million
Q4 2023

Feb 14, 2024

SELL
$24.02 - $43.89 $7.33 Million - $13.4 Million
-305,338 Reduced 74.9%
102,315 $4.13 Million
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $241,391 - $500,362
14,292 Added 3.63%
407,653 $10.7 Million
Q2 2023

Aug 11, 2023

SELL
$13.29 - $18.01 $1.75 Million - $2.38 Million
-131,947 Reduced 25.12%
393,361 $6.77 Million
Q1 2023

May 16, 2023

BUY
$7.17 - $18.55 $3.21 Million - $8.3 Million
447,691 Added 576.8%
525,308 $8.71 Million
Q4 2022

Feb 14, 2023

SELL
$6.74 - $11.52 $1.22 Million - $2.08 Million
-180,426 Reduced 69.92%
77,617 $591,000
Q3 2022

Nov 14, 2022

BUY
$7.94 - $12.36 $1.66 Million - $2.58 Million
208,650 Added 422.43%
258,043 $2.57 Million
Q2 2022

Aug 15, 2022

SELL
$5.21 - $12.14 $642,413 - $1.5 Million
-123,304 Reduced 71.4%
49,393 $448,000
Q1 2022

May 16, 2022

SELL
$7.34 - $17.16 $1.71 Million - $4.01 Million
-233,634 Reduced 57.5%
172,697 $1.75 Million
Q4 2021

Feb 14, 2022

BUY
$11.38 - $53.41 $4.05 Million - $19 Million
355,718 Added 702.82%
406,331 $6.78 Million
Q3 2021

Nov 15, 2021

BUY
$46.87 - $64.24 $1.45 Million - $1.99 Million
30,957 Added 157.49%
50,613 $2.37 Million
Q2 2021

Aug 11, 2021

BUY
$46.47 - $63.93 $622,093 - $855,830
13,387 Added 213.54%
19,656 $1.2 Million
Q1 2021

May 17, 2021

SELL
$55.47 - $72.35 $653,436 - $852,282
-11,780 Reduced 65.27%
6,269 $386,000
Q4 2020

Feb 16, 2021

SELL
$38.38 - $71.11 $86,546 - $160,353
-2,255 Reduced 11.11%
18,049 $1.28 Million
Q3 2020

Nov 16, 2020

SELL
$27.2 - $42.19 $216,811 - $336,296
-7,971 Reduced 28.19%
20,304 $761,000
Q2 2020

Aug 14, 2020

SELL
$22.22 - $35.69 $376,184 - $604,231
-16,930 Reduced 37.45%
28,275 $922,000
Q1 2020

May 15, 2020

BUY
$16.11 - $36.23 $728,252 - $1.64 Million
45,205 New
45,205 $1.31 Million
Q4 2019

Feb 14, 2020

SELL
$17.96 - $46.63 $181,000 - $469,937
-10,078 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$20.13 - $32.38 $202,870 - $326,325
10,078 New
10,078 $216,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.52B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.